<DOC>
	<DOCNO>NCT00333450</DOCNO>
	<brief_summary>To evaluate immunological memory pneumococcal vaccine serotypes child prim conjugate vaccine administer booster dose plain polysaccharide vaccine .</brief_summary>
	<brief_title>Immune Memory Evaluation Children Following Primary Vaccination With Pneumococcal Conjugate Vaccines .</brief_title>
	<detailed_description>2 group ( 60 per group ) , booster Pneumovax 23 prim Prevnar GSK Biologicals ' pneumococcal vaccine .</detailed_description>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion : healthy child 1114 month old receive primary vaccination Prevnar GSK Biologicals ' pneumococcal conjugate vaccine . Exclusion : child receive plan receive investigational product , vaccine foresee protocol immune modify drug ; child receive additional pneumococcal vaccine primary study ; child disease affect immune system history seizures and/or allergic disease .</criteria>
	<gender>All</gender>
	<minimum_age>11 Months</minimum_age>
	<maximum_age>14 Months</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>